Skip to Content
Merck
  • Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells.

Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells.

Journal of neuroscience research (2012-10-23)
Armine Darbinyan, Rafal Kaminski, Martyn K White, Nune Darbinian-Sarkissian, Kamel Khalili
ABSTRACT

Reactivation of the human polyomavirus JC (JCV) in the CNS results in a fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML). The lytic destruction of oligodendrocytes, which occurs at the terminal stage of the viral infection cycle, is considered a critical factor in the development of demyelination and the pathogenesis of PML. However, knowledge is limited about interaction of JCV with oligodendrocytes and its impact on the denudation of axons at the early stage of viral reactivation and prior to the destruction of the infected cells. We have developed an in vitro neuroprogenitor cell culture using human fetal brain that can be differentiated to the oligodendrocyte lineage to investigate interactions of JCV with its host cells. Results show that infection with JCV delays oligodendrocyte maturation as shown by reduced levels of oligodendrocytic markers, including myelin basic protein, proteolipid protein, and platelet-derived growth factor receptor-α. Furthermore, replication of JCV in these cells caused substantial dysregulation of several chemokines, including CCL5/RANTES, GRO, CXCL1/GROα, CXCL16, CXCL8/IL-8, CXCL5/ENA-78, and CXCL10/IP-10, all of which play a role in cell growth and differentiation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-A2B5 Antibody, clone A2B5-105, clone A2B5-105, Chemicon®, from mouse
Sigma-Aldrich
Anti-Galactocerebroside Antibody, clone mGalC, clone mGalC, Chemicon®, from mouse
Sigma-Aldrich
Anti-SV40 T Antigen (Ab-2) Mouse mAb (PAb416), liquid, clone PAb416, Calbiochem®